Feed LGNXZ
LG
Ligand Pharmaceuticals, Inc.
LGNXZ · OTC
$0.00 -4.76% (-$0.00)
1M -28.57%
Market Cap $42.1K
P/E Ratio 0.00x
Div. Yield -
ROE 12.44%
Valuation
100 /100
Cheap P/E 0.00x
P/S 0.00x
P/FCF 0.00x
Growth
77 /100
Growing Rev. growth 17.72%
Book val. growth 8.00%
EPS growth N/A
Profitability
62 /100
Moderate Gross margin 0.00%
Net margin 41.67%
FCF margin 11.50%
Quality
30 /100
Poor ROIC 1.20%
ROE 12.44%
Asset turnover 0.17x
Debt
96 /100
Low Debt/Equity 0.44x
Current ratio 22.23x
Net debt/EBITDA -2.28x
Stability
32 /100
Unstable Beta 0.98x
Rev. volatility 37.46%
Profitable years 2
Întreabă StockBot despre LGNXZ
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Todd C. Davis
Employees
47
Headquarters
Jupiter
Evenimente viitoare
05 NOV.
Earnings
Upcoming earnings report